Treatment of Seasonal or Perennial Allergic Conjunctivitis
Clinical Scenario
This protocol addresses patients with a confirmed diagnosis of seasonal or perennial allergic conjunctivitis — a common ocular allergic condition characterised by trigger-driven inflammation of the conjunctiva.
Condition Context
Topical pharmacological options are a recognised part of management for seasonal allergic conjunctivitis. For patients whose disease cannot be adequately controlled with standard topical therapy and oral antihistamines, consultation with an allergist or dermatologist may be appropriate.
Treatment Approach — Partial Overview
When topical therapy is insufficient, allergen-specific immunotherapy — delivered by subcutaneous or sublingual routes — is an option directed at hyposensitization to the trigger allergens. The complete protocol specifies the full regimen, sequencing, and clinical considerations.
References
- Table 2 lists topical medications that can be used for seasonal allergic conjunctivitis.
- Consultation with an allergist or dermatologist may be helpful for patients who have disease that cannot be adequately controlled with topical medications and oral antihistamines.
- Allergen-specific immunotherapy, in which increasing subcutaneous or sublingual doses of the trigger allergens are administered to achieve hyposensitization, are useful, but usage may be limited by expense, long-term patient commitment, and the risk of anaphylaxis.
View source ↗